Mass Tort Portfolio Financing: Capital for Firms Managing Large Inventories

How firms managing thousands of mass tort plaintiffs finance acquisition, development, and carrying costs.

Mass tort portfolio financing supports law firms that manage large inventories of individual plaintiffs in coordinated litigation. A firm participating in a pharmaceutical or device MDL may carry thousands of clients, each requiring intake, medical record retrieval, expert evaluation, and years of carrying cost before any settlement arrives. The capital required to build and maintain such an inventory is substantial, and portfolio financing provides it against the expected aggregate recovery of the book.

The economics of mass tort practice make external capital almost essential at scale. Client acquisition through marketing and case referral carries significant upfront cost, and the time from intake to settlement commonly spans years. A firm financing this entirely from its own resources would be constrained in how many claims it could pursue. Portfolio financing relaxes that constraint, allowing firms to build inventories large enough to participate meaningfully in global settlement negotiations, where scale confers leverage.

Funders underwrite mass tort portfolios by analyzing the inventory as a whole. The composition across different torts, the procedural posture of each relevant MDL, the strength of the underlying science, the documentation supporting each claim, and the defendant's settlement history all factor into the valuation. Concentration limits prevent overexposure to any single litigation, and diversification across multiple torts reduces the risk that one adverse scientific ruling impairs the entire book.

Draw structures align capital deployment with the rhythm of inventory building. Firms typically draw to fund acquisition and development, then repay as settlements are reached and distributions flow through qualified settlement funds. Because settlement timing in mass torts is uncertain and lien resolution can delay distributions, funders model these stages carefully and structure repayment to accommodate the realistic timeline of recovery rather than an optimistic one.

Criterica Capital underwrites mass tort portfolios using outcome models trained on 106M+ court records, including the settlement and resolution history of comparable MDL dockets. This lets us value inventories and structure draw schedules grounded in observed outcomes. Firms building or carrying mass tort inventories can contact our institutional team to discuss portfolio financing.

Discuss your matter with our institutional team.